Scientists have developed a contrast agent that selectively targets and highlights malignant micro-calcifications in the breast, while ignoring similar micro-calcifications found in benign breast conditions. The new, simpler way to detect malignant tumors will be described at the 233rd national meeting of the American Chemical Society in Chicago.
More...